Conversion of the Seattle Angina questionnaire into EQ-5D utilities for ischemic heart disease: A systematic review and catalog of the literature

ClinicoEconomics and Outcomes Research

Volumn 6, Issue 1, 2014, Pages 253-268

  Wijeysundera, Harindra C ^a,b,c,d   Farshchi Zarabi, Sara ^a   Witteman, William ^e   Bennell, Maria C ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

European Quality of Life 5 Dimensions; Health related quality of life; Ischemic heart disease; Mapping algorithm; Seattle Angina Questionnaire; Utilities

Indexed keywords

ACUTE CORONARY SYNDROME; ALGORITHM; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; ECONOMIC EVALUATION; EUROPEAN QUALITY OF LIFE 5 DIMENSIONS UTILITY SCORE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEATTLE ANGINA QUESTIONNAIRE; SYSTEMATIC REVIEW;

EID: 84901246105     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S63187     Document Type: Article

References (54)

1. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London, UK: National Institute for Clinical Excellence; 2004.
2. Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada. 3rd ed. Ottawa, ON, Canada: Canadian Agency for Drugs and Technologies in Health; 2006.
3. Longworth L, Buxton M, Sculpher M, Smith D. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ. 2005;6(4):347-353.
4. World Health Organization. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, Switzerland: World Health Organization; 2003.
5. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford, UK: Oxford University Press; 2005.
6. Llewellyn-Thomas HA. Health state descriptions. Purposes, issues, a proposal. Med Care. 1996;34(Suppl 12):DS109-DS118.
7. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095-1108.
8. Spertus JA, Winder JA, Dewhurst TA, etal. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25(2): 333-341.
9. Wijeysundera HC, Tomlinson G, Norris CM, Ghali WA, Ko DT, Krahn MD. Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Med Decis Making. 2011;31(3):481-493.
10. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53-72.
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269.
12. Spertus JA, Dewhurst T, Dougherty CM, Nichol P. Testing the effectiveness of converting patients to long-acting antianginal medications: the Quality of Life in Angina Research Trial (QUART). Am Heart J. 2001;141(4):550-558.
13. Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med. 2009;169(16): 1491-1499.
14. Makolkin VI, Osadchiy KK. Trimetazidine modified release in the treatment of stable angina: TRIUMPH studyTRImetazidine MR in patients with stable angina: unique metabolic PatH. Clin Drug Investig. 2004;24(12):731-738.
15. Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006;48(3):566-575.
16. Maxwell AJ, Zapien MP, Pearce GL, MacCallum G, Stone PH. Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol. 2002;39(1):37-45.
17. Deaton C, Kimble LP, Veledar E, etal. The synergistic effect of heart disease and diabetes on self-management, symptoms, and health status. Heart Lung. 2006;35(5):315-323.
18. Andrell P, Ekre O, Grip L, etal. Fatality, morbidity and quality of life in patients with refractory angina pectoris. Int J Cardiol. 2011;147(3): 377-382.
19. Lowe HC, Oesterle SN, He KL, MacNeill BD, Burkhoff D. Outcomes following percutaneous coronary intervention in patients previously considered "without option": a subgroup analysis of the PACIFIC trial. J Interv Cardiol. 2004;17(2):87-91.
20. Ohldin A, Young B, Derleth A, etal. Ethnic differences in satisfaction and quality of life in veterans with ischemic heart disease. J Natl Med Assoc. 2004;96(6):799-808.
21. Neil N, Ramsey SD, Cohen DJ, etal. Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trial. J Interv Cardiol. 2002;15(4):249-255.
22. Pettersen KI, Reikvam A, Stavem K. Reliability and validity of the Norwegian translation of the Seattle Angina Questionnaire following myocardial infarction. Qual Life Res. 2005;14(3):883-889.
23. Gelsomino S, Lorusso R, Livi U, etal. Cost and cost-effectiveness of cardiac surgery in elderly patients. J Thorac Cardiovasc Surg. 2011;142(5):1062-1073.
24. Fathi R, Haluska B, Short L, Marwick TH. A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention. Am J Med. 2003;114(6):445-453.
25. Moore RK, Groves D, Bateson S, etal. Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina program. Eur J Pain. 2005;9(3):305-310.
26. Graham MM, Norris CM, Galbraith PD, Knudtson ML, Ghali WA; APPROACH Investigators. Quality of life after coronary revascularization in the elderly. Eur Heart J. 2006;27(14):1690-1698.
27. Agarwal S, Schechter C, Zaman A. Assessment of functional status and quality of life after percutaneous coronary revascularisation in octogenarians. Age Ageing. 2009;38(6):748-751.
28. MacDonald P, Stadnyk K, Cossett J, Klassen G, Johnstone D, Rockwood K. Outcomes of coronary artery bypass surgery in elderly people. Can J Cardiol. 1998;14(10):1215-1222.
29. Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg. 1999;68(6):2129-2135.
30. Broddadottir H, Jensen L, Norris C, Graham M. Health-related quality of life in women with coronary artery disease. Eur J Cardiovasc Nurs. 2009;8(1):18-25.
31. Bainey KR, Norris CM, Gupta M, etal. Altered health status and quality of life in South Asians with coronary artery disease. Am Heart J. 2011;162(3):501-506.
32. Ascione R, Reeves BC, Taylor FC, Seehra HK, Angelini GD. Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J. 2004;25(9):765-770.
33. Angelini GD, Culliford L, Smith DK, etal. Effects of on-and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: long-term follow-up of 2 randomized controlled trials. J Thorac Cardiovasc Surg. 2009;137(2):295-303.
34. Karolak W, Hirsch G, Buth K, Legare JF. Medium-term outcomes of coronary artery bypass graft surgery on pump versus off pump: results from a randomized controlled trial. Am Heart J. 2007;153(4):689-695.
35. Chaudhury S, Sharma S, Pawar AA, etal. Psychological correlates of outcome after coronary artery bypass graft. Med J Armed Forces India. 2006;62(3):220-223.
36. Wagner TH, Sethi G, Holman W, etal. Costs and quality of life associated with radial artery and saphenous vein cardiac bypass surgery: results from a Veterans Affairs multisite trial. Am J Surg. 2011;202(5): 532-535.
37. de Quadros AS, Lima TC, Rodrigues AP, etal. Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice. Catheter Cardiovasc Interv. 2011;77(7):954-960.
38. Wong MS, Chair SY. Changes in health-related quality of life following percutaneous coronary intervention: a longitudinal study. Int J Nurs Stud. 2007;44(8):1334-1342.
39. Weintraub WS, Spertus JA, Kolm P, etal. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359(7): 677-687.
40. Rumsfeld JS, Alexander KP, Goff DC Jr, etal. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127(22):2233-2249.
41. Mommersteeg PM, Denollet J, Spertus JA, Pedersen SS. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J. 2009;157(2):208-218.
42. Heidenreich PA, Spertus JA, Jones PG, etal. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752-756.
43. Chan PS, Soto G, Jones PG, etal. Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation. 2009;119(3):398-407.
44. National Institute for Health and Clinical Excellence. Briefing Paper for Methods Review Workshop on Key Issues in Utility Measurement. London, UK: National Institute for Health and Clinical Excellence; 2007.
45. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2): 215-225.
46. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13.
47. Leung YW, Grewal K, Gravely-Witte S, Suskin N, Stewart DE, Grace SL. Quality of life following participation in cardiac rehabilitation programs of longer or shorter than 6 months: does duration matter? Population Health Management. 2011;14(4):181-188.
48. Zhang Z, Mahoney EM, Stables RH, etal. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation. 2003;108(14):1694-1700.
49. Kim J, Henderson RA, Pocock SJ, etal. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol. 2005;45(2):221-228.
50. Hofer S, Benzer W, Schussler G, von Steinbuchel N, Oldridge NB. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Qual Life Res. 2003;12(2):199-212.
51. Arnold SV, Morrow DA, Wang K, etal; MERLIN-TIMI 36 Investigators. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial. Circ Cardiovasc Qual Outcomes. 2008;1(2):107-115.
52. Arnold SV, Spertus JA, Jones PG, Xiao L, Cohen DJ. The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry. Am Heart J. 2009;157(6):1042-1049. e1041.
53. Asadi-Lari M, Packham C, Gray D. Gender difference in health-related needs and quality of life in patients with acute chest pain. Br J Cardiol. 2005;12(6):459-464.
54. de Jong-Watt WJ, Arthur HM. Anxiety and health-related quality of life in patients awaiting elective coronary angiography. Heart & Lung. 2004;33(4):237-248.